Alkali Metals Fair Value
Alkali Metals (ALKALI) average fair value is ₹158.16 across 5 valuation models — P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹86.81 (+82.19%), fair value range ₹0.67–₹402.15. For live price and a broader fundamental view, visit Alkali Metals share price chart.
Fair Value Analysis Export
ALKALI Fair Value vs Current Price — Valuation Summary
ALKALI average fair value, fair value range, price gap and valuation status across 5 models: P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF). Also explore ALKALI share price charts to track price trends across different timeframes.
P/B Based Valuation
Dividend Discount Model
Price-to-Sales Valuation
Asset-Based Valuation
Discounted Cash Flow (DCF)
ALKALI Fair Value Analysis — Data Sources & Coverage
Alkali Metals financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. See ALKALI P/B ratio to compare market price against book value per share.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
ALKALI vs Chemicals Sector Peers — P/E, P/B & Market Cap
Alkali Metals P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Polychem | POLYCHEM | 2.57 | 1.28 | ₹76 |
| Blue Pearl Agriventures | BPAGRI | 687.5 | 13.47 | ₹788 |
| Omkar Pharmachem | OMKARPH | 337.5 | 2.86 | ₹27 |
| PB Global | PBGLOBAL | -0.06 | 0.01 | ₹0 |
| Citurgia Biochemicals | CITURGIA | -2327.6 | -156.31 | ₹1,568 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.